NCT03039413View on ClinicalTrials.gov

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 28, 2016

Primary Completion Date

May 21, 2019

Study Completion Date

July 19, 2024

Conditions
Bladder Urothelial CarcinomaUrothelial Carcinoma
Interventions
DRUG

Copper Cu 64 TP3805

Given IV

PROCEDURE

Positron Emission Tomography

Undergo Cu-64-TP3805 Positron Emission Tomography scan

PROCEDURE

Computed Tomography

Undergo Cu-64-TP3805 Computed Tomography scan

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT03039413 - Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy | Biotech Hunter | Biotech Hunter